Nitric Oxide Synthase is Necessary for Normal Urogenital Development.

Area of Science:

• Urology
• Developmental Biology
• Physiology

Background:

• Neuronal nitric oxide synthase (NOS-I) reduction is linked to erectile dysfunction (ED) following cavernous nerve (CN) injury.
• Apoptosis and collagen deposition increase with CN injury, but NOS's role in urogenital structure maintenance remains unclear.
• Morphological changes in corpora cavernosa coincide with decreased NOS, suggesting a potential link to ED.

Purpose of the Study:

• To investigate the role of NOS in urogenital morphology during development.
• To test the hypothesis that NOS inhibition impacts urogenital development and morphology.

Main Methods:

• Rats were treated with L-NAME to inhibit NOS from postnatal day 4 for 8 days.
• Evaluated effects on penis, prostate, and bladder morphology using H&E, western blot, and TUNEL assays.
• Investigated NOS-I regulation by Sonic Hedgehog (SHH) and quantified NOS abundance via RT-PCR.

Main Results:

• L-NAME treatment increased apoptosis and altered penis, prostate, and bladder morphology.
• NOS inhibition decreased bladder weight by 25%.
• SHH inhibition reduced NOS-I in the pelvic ganglia/CN and penis; NOS-III expression varied with age and injury.

Conclusions:

• NOS is crucial for normal urogenital development.
• Decreased NOS, as seen in ED, may contribute to abnormal urogenital morphology in ED patients and models.